Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027066 · ClinicalTrials.gov registry record · Phase 3
Warfarin Versus Aspirin Recurrent Stroke Study
A Phase 3 study, sponsored by Columbia University.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,206
- Enrollment target
NCT00027066 is a Phase 3 study that has completed, run by Columbia University. The registered enrollment target is 2,206 participants.
The verdict
NCT00027066, a Phase 3 study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,206 participants
- Enrollment target
Study Summary
The goal of this study is to compare aspirin to warfarin for the prevention of recurrent stroke.
Interventions
- DRUG Aspirin placebo
- DRUG Active Aspirin
- DRUG Active Warfarin
- DRUG Warfarin placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,206 participants |
| Start Date | 1993-06 |
| Est. Completion | 2001-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00027066
The ClinicalTrials.gov registry entry for NCT00027066 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Aspirin placebo is the first listed.
NCT00027066 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00027066 about?
NCT00027066 is a clinical study titled "Warfarin Versus Aspirin Recurrent Stroke Study". The goal of this study is to compare aspirin to warfarin for the prevention of recurrent stroke.
What is the current status of trial NCT00027066?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,206 participants. The study started on 1993-06. Estimated completion is 2001-11.
What interventions are being tested in trial NCT00027066?
The interventions under investigation include: Aspirin placebo (DRUG), Active Aspirin (DRUG), Active Warfarin (DRUG), Warfarin placebo (DRUG).
Who is sponsoring clinical trial NCT00027066?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.